1. O042 Impact of supine REM AHI on diagnostic sleep studies for OSA. (7th October 2021) Authors: Callum, J; Stranks, L; Melehan, K; Yee, B Journal: Sleep advances Issue: Volume 2:Supplement 1(2021) Page Start: A19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P23 Predictors of mortality in progressive fibrosing interstitial lung disease patients treated with Nintedanib: real-world data from a single ILD specialist centre. (11th November 2022) Authors: Stranks, L; Newman, K; Garfoot, T; Morris, H; Zakis, K; Swale, J; Greaves, M; Stanel, S; Ramjug, S; Avram, C; Blaikley, J; Leonard, C; Hayton, C; Rivera-Ortega, P Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P30 Real-world tolerability study of nintedanib in patients with progressive fibrosing interstitial lung disease compared to patients with idiopathic pulmonary fibrosis. (11th November 2022) Authors: Newman, K; Garfoot, T; Stranks, L; Morris, H; Zakis, K; Swale, J; Greaves, M; Stanel, S; Ramjug, S; Avram, C; Blaikley, J; Leonard, C; Hayton, C; Rivera-Ortega, P Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗